bf/AMEX:LCTX_icon.png

COM:LINEAGECELL

Lineage Cell Therapeutics, Inc.

  • Stock

USD

Last Close

0.60

22/11 21:00

Market Cap

180.52M

Beta: -

Volume Today

2.48K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.05
-
0.03
47.57%
0.03
3.02%
0.02
40.99%
0.01
34.51%
0.01
34.66%
0.01
15.43%
0.01
39.21%
0.02
211.71%
0.12
432.66%
0.09
25.52%
cash conversion cycle
-1.71K
-
-2.58K
51.30%
-685.28
73.48%
-7.10K
935.51%
-1.42K
80.02%
-6.85K
383.43%
1.28K
118.71%
-2.47K
292.90%
3.86K
255.90%
-1.19K
130.92%
-518.57
56.51%
cash per share
0.10
-
0.44
337.75%
0.54
21.55%
0.23
56.71%
0.33
42.87%
0.24
27.36%
0.21
12.87%
0.28
31.24%
0.35
28.07%
0.34
3.92%
0.21
39.69%
company equity multiplier
3.90
-
2.05
47.33%
3.52
71.33%
1.21
65.66%
1.07
11.89%
1.08
1.70%
1.11
2.54%
1.12
1.02%
1.89
68.67%
1.69
10.91%
1.59
5.53%
days of inventory outstanding
82.28
-
116.00
40.97%
0.33
99.72%
days of payables outstanding
1.79K
-
2.97K
65.70%
922.56
68.90%
7.28K
689.51%
2.04K
72.02%
7.81K
283.30%
4.63K
40.73%
2.48K
46.53%
906.87
63.36%
1.20K
32.30%
548.97
54.24%
days of sales outstanding
266.26
-
236.95
11.01%
187.52
20.86%
620.42
230.85%
958.64
54.52%
5.91K
516.72%
1.89
99.97%
4.76K
252,077.36%
7.37
99.85%
30.40
312.31%
dividend yield
0.00
-
0.30
16,053.10%
0.00
99.90%
0.10
30,735.17%
0.02
81.14%
0.00
-
ebit per revenue
-19.57
-
-26.04
33.07%
-25.97
0.27%
-26.18
0.82%
-21.71
17.09%
-29.52
35.97%
-26.30
10.89%
-34.21
30.07%
-12.63
63.08%
-1.53
87.87%
-2.77
80.52%
ebt per ebit
1.00
-
1.01
0.56%
0.95
5.68%
-0.32
133.17%
0.60
289.58%
1.13
88.36%
0.49
56.13%
0.83
67.55%
0.88
6.07%
1.15
30.36%
0.94
17.87%
effective tax rate
0.06
-
0.14
146.95%
0.07
50.01%
-9.45
13,208.36%
1.60
116.95%
0.01
99.54%
0.39
5,145.59%
0.06
85.32%
0.11
92.45%
-0.02
119.27%
0.08
469.49%
enterprise value multiple
-11.08
-
-4.32
61.01%
-4.59
6.13%
-2.34
48.97%
-3.91
66.91%
-2.93
25.12%
-2.31
21.18%
-9.39
307.15%
-6.63
29.36%
-9.64
45.44%
-6.48
32.84%
fixed asset turnover
0.95
-
0.68
28.64%
0.34
50.65%
0.41
21.18%
0.32
20.48%
0.24
25.07%
0.18
25.50%
0.14
24.06%
0.80
482.43%
2.59
224.10%
1.88
27.60%
free cash flow per share
-0.59
-
-0.59
0.97%
-0.63
5.73%
-0.46
26.34%
-0.28
39.65%
-0.27
3.20%
-0.22
17.35%
-0.13
40.65%
-0.15
10.07%
0.00
102.62%
-0.17
4,551.05%
gross profit margin
0.72
-
0.57
21.16%
0.56
1.19%
0.84
49.35%
0.91
7.75%
0.79
13.19%
0.72
8.32%
0.50
30.41%
0.63
26.31%
0.95
49.92%
0.85
10.82%
interest coverage
-2.15
-
7.36
442.99%
3.66
50.31%
0.76
79.22%
2.24
194.74%
-3.84
271.62%
-23.07
500.16%
-4.35
-
inventory turnover
4.44
-
3.15
29.07%
1.11K
35,081.37%
long term debt to capitalization
0.01
-
0.16
1,305.09%
0.02
84.88%
0.01
69.74%
0.02
186.41%
0.03
65.11%
0.03
23.77%
0.02
18.66%
0.04
84.43%
0.03
18.10%
net income per ebt
0.78
-
0.71
8.86%
0.75
5.38%
1.80
140.37%
0.86
52.42%
0.98
13.76%
0.61
36.99%
0.94
53.44%
0.89
5.54%
1.02
14.55%
0.92
9.61%
net profit margin
-15.34
-
-18.71
21.97%
-18.54
0.87%
14.91
180.39%
-11.15
174.78%
-32.48
191.36%
-8.00
75.36%
-26.76
234.41%
-9.90
63.01%
-1.79
81.89%
-2.40
34.01%
operating cash flow per share
-0.54
-
-0.58
7.42%
-0.56
4.40%
-0.43
22.17%
-0.27
38.71%
-0.24
8.71%
-0.22
9.79%
-0.13
40.03%
-0.14
8.79%
0.01
104.35%
-0.17
2,752.60%
operating cycle
82.28
-
382.26
364.56%
237.28
37.93%
187.52
20.97%
620.42
230.85%
958.64
54.52%
5.91K
516.72%
1.89
99.97%
4.76K
252,077.36%
7.37
99.85%
30.40
312.31%
operating profit margin
-19.57
-
-26.04
33.07%
-25.97
0.27%
-26.18
0.82%
-21.71
17.09%
-29.52
35.97%
-26.30
10.89%
-34.21
30.07%
-12.63
63.08%
-1.53
87.87%
-2.77
80.52%
payables turnover
0.20
-
0.12
39.65%
0.40
221.56%
0.05
87.33%
0.18
257.41%
0.05
73.91%
0.08
68.72%
0.15
87.04%
0.40
172.96%
0.30
24.41%
0.66
118.55%
pretax profit margin
-19.64
-
-26.28
33.82%
-24.72
5.93%
8.27
133.44%
-13.00
257.17%
-33.28
156.11%
-13.01
60.90%
-28.36
117.94%
-11.11
60.84%
-1.76
84.19%
-2.60
48.26%
price fair value
13.19
-
6.80
48.44%
12.15
78.71%
2.98
75.49%
1.51
49.20%
1.23
18.68%
1.15
6.82%
2.75
139.40%
4.37
59.20%
2.71
38.02%
2.97
9.56%
receivables turnover
1.37
-
1.54
12.37%
1.95
26.36%
0.59
69.77%
0.38
35.28%
0.06
83.79%
193.25
312,917.93%
0.08
99.96%
49.51
64,500.53%
12.01
75.75%
return on assets
-0.76
-
-0.49
36.05%
-0.50
2.12%
0.24
147.43%
-0.12
148.97%
-0.45
292.33%
-0.09
79.16%
-0.19
103.30%
-0.22
15.30%
-0.21
3.55%
-0.21
0.19%
return on capital employed
-1.10
-
-0.75
32.18%
-0.80
7.06%
-0.44
44.92%
-0.23
46.97%
-0.44
88.44%
-0.33
25.85%
-0.26
19.20%
-0.39
46.28%
-0.22
44.29%
-0.30
38.42%
return on equity
-2.96
-
-1.00
66.31%
-1.75
74.96%
0.28
116.29%
-0.12
143.14%
-0.49
299.02%
-0.10
78.64%
-0.22
105.37%
-0.42
94.48%
-0.36
14.07%
-0.34
5.72%
total debt to capitalization
0.01
-
0.16
1,019.29%
0.03
79.52%
0.01
71.41%
0.02
152.40%
0.04
85.63%
0.03
24.15%
0.03
11.14%
0.05
71.07%
0.04
11.83%

All numbers in USD (except ratios and percentages)